| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |